BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6407770)

  • 1. Reversible microangiopathic hemolytic anemia after mitomycin C.
    Perry DJ
    Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
    Waldhorn RE; Tsou E; Smith FP; Kerwin DM
    Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K; Fukui H; Otsuka Y; Hattori S
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract]   [Full Text] [Related]  

  • 4. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL; Berkovic M
    J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
    Grem JL; Merritt JA; Carbone PP
    Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
    Ito S; Hirono S
    Rinsho Ketsueki; 1982 May; 23(5):730-5. PubMed ID: 6813535
    [No Abstract]   [Full Text] [Related]  

  • 9. Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patients.
    Bruntsch U; Groos G; Tigges FJ; Gallmeier WM
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):905-9. PubMed ID: 6540191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
    Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
    McCarthy JT; Staats BA
    Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
    Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
    Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin-C.
    Lempert KD
    Lancet; 1980 Aug; 2(8190):369-70. PubMed ID: 6105503
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal failure and hemolytic anemia associated with mitomycin C. A case report.
    Price TM; Murgo AJ; Keveney JJ; Miller-Hardy D; Kasprisin DO
    Cancer; 1985 Jan; 55(1):51-6. PubMed ID: 3917354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rash, nephritis, hypertension, and haemolysis in patient on 5-fluorouracil, doxorubicin, and mitomycin-C.
    Karlin DA; Stroehlein JR
    Lancet; 1980 Sep; 2(8193):534-5. PubMed ID: 6105582
    [No Abstract]   [Full Text] [Related]  

  • 17. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
    Sheldon R; Slaughter D
    Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic agents and the erythron.
    Doll DC; Weiss RB
    Cancer Treat Rev; 1983 Sep; 10(3):185-200. PubMed ID: 6413059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microangiopathic hemolytic anemia associated with gastric cancer].
    Kanou T; Nosou Y; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T; Miura K; Kuramoto J
    Gan No Rinsho; 1986 Aug; 32(9):1029-34. PubMed ID: 3091884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; GutiƩrrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.